Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
The decision is based on the phase 3 DESTINY-Breast11 trial
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Doctors at the hospital highlighted that robotic-assisted surgery enhances precision through superior 3D visualisation and improved instrument flexibility
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
Subscribe To Our Newsletter & Stay Updated
